Bulletin
Cytarabine Injection
18 November 2009
Products Affected - Description
Cytarabine injection (powder for reconstitution), Bedford
1 gram vial (NDC 55390-0133-01)
1 gram (Novaplus) vial (NDC 55390-0808-01)
2 gram vial (NDC 55390-0134-01)
2 gram (Novaplus) vial (NDC 55390-0809-01)
Cytarabine injection, Hospira
1 gram, 20 mg/mL, 50 mL vial (NDC 61703-0303-46)
2 gram, 100 mg/mL, 20 mL vial (NDC 61703-0319-22)
Reason for the Shortage
Bedford states the shortage is due to manufacturing delays.
Estimated Resupply Dates
- APP has their cytarabine 20 mL vial (NDC 63323-0120-20) available.
- Bedford has cytarabine available in the 100 mg vial (NDC 55390-0131-10), 100 mg Novaplus vial (NDC 55390-0806-10), 500 mg vial (NDC 55390-0132-10), and 500 mg Novaplus vial (NDC 55390-0807-10). All 1 gram and 2 gram presentations are on back order with no release date.
- Hospira has cytarabine available in the 100 mg vial (NDC 61703-0305-38) and 500 mg vial (NDC 61703-0304-36). The 1 gram vial and 2 gram vial are on back order and the company cannot estimate a release date.
Related Shortages
Updated
November 18, 2009; October 21, 2009; September 14, 2009; August 6, 2009; July 22, 2009; June 22, 2009; June 11, 2009; May 4, 2009; April 6, 2009; March 3, 2009; February 10, 2009; January 6, 2009; November 17, 2008; October 16, 2008; September 12, 2008; September 3, 2008; September 2, 2008; August 7, 2008; July 14, 2008; July 11, 2008; July 7, 2008; June 27, 2008; June 3, 2008, Copyright 2009, University of Utah, Drug Information Service.
Back to Drug Shortage Product Bulletins